Fny Investment Advisers, LLC Seelos Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$0.66 - $1.22 $660 - $1,220	-1,000 Reduced 33.33%	2,000 $2,000
Q4 2022 Jan 10, 2023	SELL	$0.66 - $259.46 $330 - $129,729	-500 Reduced 14.29%	3,000 $2,000
Q3 2022 Oct 19, 2022	SELL	$0.65 - $278.68 $1,300 - $557,360	-2,000 Reduced 36.36%	3,500 $3,000
Q2 2022 Jul 12, 2022	BUY	$0.51 - $0.93 $255 - $465	500 Added 10.0%	5,500 $3,000
Q1 2022 Apr 25, 2022	BUY	$0.84 - $1.71 $4,200 - $8,550	5,000 New	5,000 $4,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.